These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38447202)

  • 21. In vivo lifetime and anti-cancer efficacy of doxorubicin-loaded nanogels composed of cinnamoyl poly (β-cyclodextrin) and cinnamoyl Pluronic F127.
    Yoon DY; Kim JC
    J Biomater Sci Polym Ed; 2017 Apr; 28(6):505-518. PubMed ID: 28081674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery.
    Ding J; Xu W; Zhang Y; Sun D; Xiao C; Liu D; Zhu X; Chen X
    J Control Release; 2013 Dec; 172(2):444-55. PubMed ID: 23742879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
    Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
    Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
    Yang C; Li C; Zhang P; Wu W; Jiang X
    Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of a dual cored hepatoma-specific star glycopolymer nanogel via arm-first ATRP approach.
    Lou S; Zhang X; Zhang M; Ji S; Wang W; Zhang J; Li C; Kong D
    Int J Nanomedicine; 2017; 12():3653-3664. PubMed ID: 28553105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
    Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
    Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green-step assembly of low density lipoprotein/sodium carboxymethyl cellulose nanogels for facile loading and pH-dependent release of doxorubicin.
    He L; Liang H; Lin L; Shah BR; Li Y; Chen Y; Li B
    Colloids Surf B Biointerfaces; 2015 Feb; 126():288-96. PubMed ID: 25576811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioreducible heparin-based nanogel drug delivery system.
    Wu W; Yao W; Wang X; Xie C; Zhang J; Jiang X
    Biomaterials; 2015 Jan; 39():260-8. PubMed ID: 25468376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three generations of thiolated cyclodextrins: A direct comparison of their mucus permeating and mucoadhesive properties.
    Haddadzadegan S; Knoll P; Wibel R; Kali G; Bernkop-Schnürch A
    Acta Biomater; 2023 Sep; 167():309-320. PubMed ID: 37271247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging.
    Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and Physicochemical Characterization of Hyaluronic Acid-Lysine Nanogels Containing Serratiopeptidase to Control Biofilm Formation.
    Mahdiani H; Yazdani F; Khoramipour M; Valizadeh V; Bakhshandeh H; Dinarvand R
    Sci Rep; 2024 Mar; 14(1):6111. PubMed ID: 38480832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiolation of non-ionic surfactants for the development of lipid-based mucoadhesive drug delivery systems.
    Racaniello GF; Knoll P; Jörgensen AM; Arduino I; Laquintana V; Lopedota AA; Bernkop-Schnürch A; Denora N
    Eur J Pharm Biopharm; 2022 Oct; 179():95-104. PubMed ID: 36058444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder.
    Kaldybekov DB; Tonglairoum P; Opanasopit P; Khutoryanskiy VV
    Eur J Pharm Sci; 2018 Jan; 111():83-90. PubMed ID: 28958893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
    Wei X; Senanayake TH; Warren G; Vinogradov SV
    Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage-mediated tumor homing of hyaluronic acid nanogels loaded with polypyrrole and anticancer drug for targeted combinational photothermo-chemotherapy.
    Xiao T; Hu W; Fan Y; Shen M; Shi X
    Theranostics; 2021; 11(14):7057-7071. PubMed ID: 34093871
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids.
    Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R
    J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma.
    Zhang M; Asghar S; Tian C; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y
    Carbohydr Polym; 2021 Feb; 253():117194. PubMed ID: 33278970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uniform Core-Shell Nanoparticles with Thiolated Hyaluronic Acid Coating to Enhance Oral Delivery of Insulin.
    Tian H; He Z; Sun C; Yang C; Zhao P; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
    Adv Healthc Mater; 2018 Sep; 7(17):e1800285. PubMed ID: 29984479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and
    Aleanizy FS; Taha EI; Salem-Bekhit MM; Felimban AMJ; Al-Suwayeh SA; Al-Joufi FA; Muharram MM; Alqahtani FY; Shakeel F; Youssof AME; Bayomi M; Abouelela AEF
    Drug Dev Ind Pharm; 2021 Dec; 47(12):1935-1942. PubMed ID: 35537065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.